After extensive and innovative research and a patent pending in 2020, Future Pharm is excited to announce the release of HEMPLETS™ Liposome Tablets.
What is HEMPLETS™?
HEMPLETS is the only liposomal chewable tablet in the world that has a patent-pending liposome platform. It is designed to have an average particle distribution of 165 Nanometers, increases oral absorbance and bioavailability. HEMPLETS is designed to deliver a potent dose of CBD that is THC-free in an oral tablet form unlike anything else. HEMPLETS is a highly advanced technology in a solid convenient chewable dosage form.
Why liposomal delivery in HEMPLETS?
A liposome is a protective lipid layer that encapsulates CBD molecules by using liposomes as carriers. This led to the development of a completely new range of CBD products that is patent pending. HEMPLETS liposomal CBD delivers products in chewable flavors that are unmatched in quality and scientifically proven while providing a fast and effective form of CBD supplementation.
What else makes HEMPLETS unique?
CBD is supplied in the USA by cGMP, FDA-registered manufacturers using CO2 extraction. The solvent is considered a cleaner, purer form of extraction because there is no residue after extraction. HEMPLETS Liposome Chewable Tablets use all-natural flavors and ingredients.
A liposome is a sort of protective lipid sphere that encapsulates CBD molecules that is using liposomal spheres as carriers. This led to the development of a completely new range of CBD chewable products that are now patent pending.
HEMPLETS liposomal CBD line delivers products in tasty chewable flavors that is unmatched quality while providing a faster and more effective form of CBD supplementation.